Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
8.1 USD | +1.25% | +1.25% | +575.00% |
Business Summary
Number of employees: 8
Sales per Business
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
Natural Bioactive Ingredients
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Sales per region
USD in Million | 2022 | Weight | 2023 | Weight | Delta |
---|---|---|---|---|---|
United States
100.0
%
| 0 | nan % | 0 | 100.0 % | - |
Managers
Managers | Title | Age | Since |
---|---|---|---|
John Payne
CEO | Chief Executive Officer | 76 | 13-07-18 |
Keith Marchiando
DFI | Director of Finance/CFO | 61 | 20-12-31 |
Laura Belicka
CTO | Chief Tech/Sci/R&D Officer | - | 21-06-30 |
Harlan L. Miller
CTO | Chief Tech/Sci/R&D Officer | - | - |
Chief Tech/Sci/R&D Officer | - | 13-04-30 | |
William P. Pfund
CTO | Chief Tech/Sci/R&D Officer | - | 18-02-28 |
Members of the board
Members of the board | Title | Age | Since |
---|---|---|---|
Director/Board Member | 77 | 14-09-16 | |
Director/Board Member | 58 | 13-08-27 | |
John Payne
CEO | Chief Executive Officer | 76 | 13-07-18 |
Alison Cornell
BRD | Director/Board Member | 62 | 21-02-07 |
Share class
Vote | Quantity | Free-Float | Company-owned shares | Total Float | |
---|---|---|---|---|---|
Stock A | 1 | 2,777,639 | 1,650,527 ( 59.42 %) | 0 | 59.42 % |
Company contact information
Zivo Bioscience, Inc.
21 East Long Lake Road Suite 100
48304, Bloomfield Hills
+(248) 452 9866
http://www.zivobioscience.comSector
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+575.00% | 22.7M | |
+8.20% | 7.78B | |
+10.20% | 6.52B | |
-8.10% | 3.67B | |
-13.13% | 3.44B | |
-14.57% | 1.17B | |
+8.34% | 934M | |
-42.27% | 879M | |
-18.90% | 836M | |
-16.45% | 802M |
- Stock Market
- Equities
- ZIVO Stock
- Company ZIVO Bioscience, Inc.